1. Home
  2. SJ vs AKTX Comparison

SJ vs AKTX Comparison

Compare SJ & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SJ
  • AKTX
  • Stock Information
  • Founded
  • SJ 2011
  • AKTX N/A
  • Country
  • SJ China
  • AKTX United States
  • Employees
  • SJ N/A
  • AKTX N/A
  • Industry
  • SJ EDP Services
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SJ Technology
  • AKTX Health Care
  • Exchange
  • SJ Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • SJ 32.0M
  • AKTX 35.7M
  • IPO Year
  • SJ N/A
  • AKTX N/A
  • Fundamental
  • Price
  • SJ $0.73
  • AKTX $0.76
  • Analyst Decision
  • SJ
  • AKTX Strong Buy
  • Analyst Count
  • SJ 0
  • AKTX 2
  • Target Price
  • SJ N/A
  • AKTX $3.30
  • AVG Volume (30 Days)
  • SJ 34.1K
  • AKTX 91.6K
  • Earning Date
  • SJ 08-27-2025
  • AKTX 08-13-2025
  • Dividend Yield
  • SJ N/A
  • AKTX N/A
  • EPS Growth
  • SJ N/A
  • AKTX N/A
  • EPS
  • SJ 0.04
  • AKTX N/A
  • Revenue
  • SJ $185,461,906.00
  • AKTX N/A
  • Revenue This Year
  • SJ N/A
  • AKTX N/A
  • Revenue Next Year
  • SJ N/A
  • AKTX N/A
  • P/E Ratio
  • SJ $20.46
  • AKTX N/A
  • Revenue Growth
  • SJ N/A
  • AKTX N/A
  • 52 Week Low
  • SJ $0.58
  • AKTX $0.57
  • 52 Week High
  • SJ $1.16
  • AKTX $3.85
  • Technical
  • Relative Strength Index (RSI)
  • SJ 48.18
  • AKTX 37.47
  • Support Level
  • SJ $0.68
  • AKTX $0.75
  • Resistance Level
  • SJ $0.77
  • AKTX $0.89
  • Average True Range (ATR)
  • SJ 0.08
  • AKTX 0.07
  • MACD
  • SJ 0.01
  • AKTX 0.01
  • Stochastic Oscillator
  • SJ 78.95
  • AKTX 57.86

About SJ Scienjoy Holding Corporation

Scienjoy Holding Corp is a provider of mobile live streaming platforms in China and focuses on interactive show live streaming from broadcasters to users. It operates a mobile live streaming business by which it provides live streaming entertainment from professional broadcasters to end-users, allowing for the operation of live social video communities. Using its mobile applications, users can select broadcasters and enter real-time video rooms to interact with them. In addition to the real-time interaction, users can also view photos posted by broadcasters in their personal pages, leave comments, and engage in private chats with broadcasters when such broadcasters are not streaming. In addition, users can also play simple, fun games using virtual currencies within the video rooms.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

Share on Social Networks: